Meeting
2018 Genitourinary Cancers Symposium
68-Ga-PSMA-PET in lymph node staging in PSA recurrent prostate cancer-does the primary influence the result?
Authors
David Pfister
University Hospital of Cologne, Cologne, Germany
David Pfister , Tobias Kohl , Daniel Porres-Knoblauch , Friederike Haidl , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 210)
DOI
10.1200/JCO.2018.36.6_suppl.210
Abstract #
210
Poster Bd #
K8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer.
First Author: Constantinos Zamboglou
Poster
2023 ASCO Genitourinary Cancers Symposium
Patterns of failure with 18F-DCFPyL PSMA PET/CT in the post-prostatectomy setting: A regional cohort analysis.
First Author: Samantha S. Sigurdson
Poster
2020 Genitourinary Cancers Symposium
Impact of 18F-fluciclovine PET on salvage radiotherapy plans for men with post-radical prostatectomy recurrence of prostate cancer.
First Author: Heather Ann Payne
Poster
2019 Genitourinary Cancers Symposium
Biochemichal recurrence in prostate cancer after salvage surgery in correlation to the site of reccurrent disease.
First Author: David Pfister